Foxo Technologies Inc
FOXO0.092USD
0.000
Cierre 11/04, 16:00（ET）Cotizaciones retrasadas 15 min
31.56KCap. mercado
PérdidaP/E TTM
Más Datos de Foxo Technologies Inc Compañía
FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
Información de Foxo Technologies Inc
Símbolo de cotizaciónFOXO
Nombre de la empresaFoxo Technologies Inc
Fecha de salida a bolsaDec 11, 2020
Director ejecutivoMr. Seamus Lagan
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 11
Dirección477 South Rosemary Avenue
CiudadWEST PALM BEACH
Bolsa de valoresUS 'Other OTC' and Grey Market
PaísUnited States of America
Código postal33401
Teléfono16128000059
Sitio Webhttp://delwinds.com/
Símbolo de cotizaciónFOXO
Fecha de salida a bolsaDec 11, 2020
Director ejecutivoMr. Seamus Lagan
Ejecutivos de Foxo Technologies Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Bret Barnes
Mr. Bret Barnes
Director
Director
168.00
+0.60%
Mr. Mark K. White
Mr. Mark K. White
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Chairman of the Board
Chairman of the Board
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Sylwia Hauman
Sylwia Hauman
Chief Financial Officer
Chief Financial Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Bret Barnes
Mr. Bret Barnes
Director
Director
168.00
+0.60%
Mr. Mark K. White
Mr. Mark K. White
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Chairman of the Board
Chairman of the Board
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Sylwia Hauman
Sylwia Hauman
Chief Financial Officer
Chief Financial Officer
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mié., 22 de oct
Actualizado: mié., 22 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Rennova Health, Inc.
0.07%
UBS Financial Services, Inc.
0.06%
Jane Street Capital, L.L.C.
0.02%
Two Sigma Investments, LP
0.02%
Kr8 ai Inc
0.02%
Otro
99.81%
Accionistas
Accionistas
Proporción
Rennova Health, Inc.
0.07%
UBS Financial Services, Inc.
0.06%
Jane Street Capital, L.L.C.
0.02%
Two Sigma Investments, LP
0.02%
Kr8 ai Inc
0.02%
Otro
99.81%
Tipos de accionistas
Accionistas
Proporción
Corporation
0.08%
Investment Advisor
0.08%
Research Firm
0.04%
Hedge Fund
0.02%
Otro
99.78%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
34
113.13K
0.15%
+74.26K
2025Q2
43
122.62K
2.30%
-40.72K
2025Q1
44
283.42K
16.93%
-74.76K
2024Q4
45
2.97M
12.59%
-305.11K
2024Q3
42
2.93M
22.70%
-1.57M
2024Q2
66
3.17M
26.93%
-1.03M
2024Q1
108
4.13M
45.76%
-1.73M
2023Q4
115
3.33M
41.62%
-1.13M
2023Q3
119
2.33M
33.97%
-1.67M
2023Q2
124
2.96M
79.90%
-804.39K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Rennova Health, Inc.
51.44K
0.07%
+2.00
+0.00%
Sep 10, 2025
UBS Financial Services, Inc.
44.67K
0.06%
+37.12K
+491.99%
Jun 30, 2025
Jane Street Capital, L.L.C.
17.70K
0.02%
+17.70K
--
Jun 30, 2025
Two Sigma Investments, LP
16.26K
0.02%
+16.26K
--
Jun 30, 2025
Kr8 ai Inc
11.91K
0.02%
+1.00
+0.01%
Sep 10, 2025
SBI Securities Co., Ltd.
9.66K
0.01%
+7.10K
+277.06%
Jun 30, 2025
Cantor Fitzgerald, L.P
9.57K
0.01%
+8.62K
+900.21%
Jun 30, 2025
HRT Financial LP
6.83K
0.01%
+6.83K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
6.42K
0.01%
-819.00
-11.32%
Jun 30, 2025
Corbin Capital Partners, L.P.
1.38K
0%
--
--
Dec 31, 2024
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Nov 15, 2024
Merger
0→0
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Fecha
Tipo
Relación
Nov 15, 2024
Merger
0→0
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
